Clinical Trial Update: Targeted Treatment for RET Fusion-Positive Advanced Non-Small Cell Lung Cancer (A LUNG-MAP Treatment Trial) [Phase 2]

View source ↗

Summary

This Clinical Trials update describes the Phase 2 A LUNG-MAP trial evaluating targeted therapy for RET fusion-positive advanced non-small cell lung cancer, curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 | Phase 2 | Status: ACTIVE_NOT_RECRUITING